Aldeyra Therapeutics, Inc. (ALDX)

CIK 1341235 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aldeyra Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 2026SCHEDULE 13G0001167557-26-000132
Aug 6, 202610-Q0001341235-26-000010
Jul 30, 20268-K0001193125-26-326337
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002166
Jul 15, 20268-K0001193125-26-304880
Jun 11, 202640001193125-26-267623
Jun 11, 202640001193125-26-267634
Jun 11, 202640001193125-26-267587
Jun 11, 202640001193125-26-267605
Jun 11, 202630001193125-26-267553
Jun 11, 202640001193125-26-267600
Jun 11, 202640001193125-26-267629
Jun 11, 202640001193125-26-267611
Jun 10, 20268-K0001193125-26-264514
Jun 5, 202640001193125-26-259637
May 15, 2026SCHEDULE 13G/A0001193125-26-226558
May 7, 202610-Q0001341235-26-000006
May 1, 20268-K0001193125-26-199157
Apr 27, 2026DEFA14A0001193125-26-182118
Apr 27, 2026DEF 14A0001193125-26-182099
Apr 27, 2026ARS0001193125-26-182133
Apr 20, 20268-K0001193125-26-164198
Apr 1, 20268-K0001193125-26-137984
Mar 31, 202640001193125-26-134631
Mar 26, 2026SCHEDULE 13G/A0000102909-26-000589